AbstractSingle cord blood unit (CBU) predominance is usually established within the first month after double umbilical cord blood transplantation (UCBT). However, the kinetics of engraftment of the different leukocyte subsets and the mechanism of graft predominance is largely unknown. To investigate whether a differential engraftment might reveal a specific subset that could play a key role in the mechanism of graft predominance, we studied early engraftment kinetics of different leukocyte subpopulations by flow cytometry using human monoclonal antigen–specific human leukocyte antigen antibodies, directed against mismatched human leukocyte antigen-A or –B antigens between recipient and CBUs. Twenty-two patients, who had received a double UC...
Background: Lower incidence and severity of acute graft versus host disease (GVHD) has been observed...
International audienceBACKGROUND:Natural killer (NK) cell alloreactivity is favored after double umb...
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
AbstractSingle cord blood unit (CBU) predominance is usually established within the first month afte...
Cord blood transplantation (CBT) is a promising alternative means of allogeneic stem cell transplant...
The transplantation of two cord blood (CB) units obtained from unrelated donors (double CBT) is an e...
AbstractSustained hematopoiesis after double-unit cord blood transplantation (dCBT) is mediated by 1...
AbstractSingle-donor dominance is observed in the majority of patients following double-unit cord bl...
AbstractThe impact of human leukocyte antigen (HLA) donor-specific antibodies (DSA) on cord blood (C...
After double-cord blood transplantation, long-term hematopoietic dominance of a single-cord blood do...
AbstractUmbilical cord blood (UCB) transplantation is limited by the low number of hematopoietic ste...
textabstractDouble umbilical cord blood transplantation is increasingly applied in the treatment of ...
AbstractAlthough umbilical cord blood has been increasingly used as an alternative donor source to t...
International audience; Usually, after double umbilical cord blood transplantation (DUCBT), only 1 o...
Double unit cord blood (CB) transplantation (CBT) appears to augment engraftment despite only one un...
Background: Lower incidence and severity of acute graft versus host disease (GVHD) has been observed...
International audienceBACKGROUND:Natural killer (NK) cell alloreactivity is favored after double umb...
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease
AbstractSingle cord blood unit (CBU) predominance is usually established within the first month afte...
Cord blood transplantation (CBT) is a promising alternative means of allogeneic stem cell transplant...
The transplantation of two cord blood (CB) units obtained from unrelated donors (double CBT) is an e...
AbstractSustained hematopoiesis after double-unit cord blood transplantation (dCBT) is mediated by 1...
AbstractSingle-donor dominance is observed in the majority of patients following double-unit cord bl...
AbstractThe impact of human leukocyte antigen (HLA) donor-specific antibodies (DSA) on cord blood (C...
After double-cord blood transplantation, long-term hematopoietic dominance of a single-cord blood do...
AbstractUmbilical cord blood (UCB) transplantation is limited by the low number of hematopoietic ste...
textabstractDouble umbilical cord blood transplantation is increasingly applied in the treatment of ...
AbstractAlthough umbilical cord blood has been increasingly used as an alternative donor source to t...
International audience; Usually, after double umbilical cord blood transplantation (DUCBT), only 1 o...
Double unit cord blood (CB) transplantation (CBT) appears to augment engraftment despite only one un...
Background: Lower incidence and severity of acute graft versus host disease (GVHD) has been observed...
International audienceBACKGROUND:Natural killer (NK) cell alloreactivity is favored after double umb...
Immunobiology of allogeneic stem cell transplantation and immunotherapy of hematological disease